In 2023, China's share of top-cited publications in endocrinology stood below the projected 2024 figure of 14.39%. The forecast highlights a consistent increase, with values reaching 14.39% in 2024, 14.81% in 2025, 15.22% in 2026, 15.6% in 2027, and 15.97% in 2028. Year-on-year growth averages roughly 0.4 percentage points, indicating steady advances in publication impact.

Future trends to watch for:

China's increasing focus on high-impact research could continue this upward trajectory beyond 2028.
Investment in R&D, talent development, and international collaborations may further enhance research quality.
Global shifts in research priorities could affect these trends.